Skip to content
  • Home
  • People
  • Research
  • Education
  • Outreach
  • News and Media

A biotech company focused on inherited diseases just raised $135 million from a bunch of Wall Street firms
Business Insider, September 2017

by
Categories Media
Post navigation

Clinical Trial Study Design: ‘One Size Does Not Fit All’
Outsourcing-Pharma.com, April 2017

Optimal Financing for R&D-Intensive Firms

Research Publications

  • Machine Learning with Statistical Imputation for Predicting Drug Approvals
  • A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer
  • Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design
  • Estimation of Clinical Trial Success Rates and Related Parameters
  • New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics

Working Papers

  • Measuring the Economic and Academic Impact of Philanthropy: The Breast Cancer Research Foundation
  • Funding Long Shots
  • Venture Philanthropy: A Case Study of the Cystic Fibrosis Foundation
  • Optimal Financing for R&D-Intensive Firms
  • Sharing R&D Risk in Healthcare via FDA Hedges

Recent Events

  • Ovarian CanceRx – June 10, 2019

  • Reconfiguring the Landscape for the Alzheimer’s Challenge II – October 11-13, 2018

  • New Approaches to Biomedical Innovation – May 31, 2018

  • Reconfiguring the Landscape for the Alzheimer’s Challenge – February 1, 2018

  • CancerRx – October 26-28, 2016

  • See all events >>

© 2024 MIT Laboratory for Financial Engineering